Molecular super enhancers: A new key for targeted therapy of brain cancer in children

(German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)) Ependymoma refers to a heterogeneous group of cancers that can occur at any age and is one of the most common types of brain cancer in children. The genetic causes for its development are largely unknown and there are no targeted treatments to date. Scientists from the Hopp Children's Cancer Center at the NCT Heidelberg, in collaboration with colleagues from the US and Canada, have now developed a molecular approach that opens new treatment prospects.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news